A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis

Nagesh HN; Anil Kumar Nagaraj; Kishore MS; Narendra kumar MS

doi:10.5455/njppp.2017.7.0721202082016

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 17 Aug 2016

Natl J Physiol Pharm Pharmacol. 2017; 7(1): 94-98

doi: 10.5455/njppp.2017.7.0721202082016

A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis

Nagesh Hn, Anil Kumar Nagaraj, Kishore Ms, Narendra Kumar Ms.

Abstract
Background: Second-generation antipsychotics (SGAs) are better for psychotic disorders, and they can induce weight gain and other serious metabolic adverse effects which can lead to non-adherence and medical comorbidities. Iloperidone and asenapine, the newer SGAs with favorable short-term side effect profile.

Aims and Objective: The aim of this study was to compare the weight gain propensity associated with new SGAs drugs-asenapine and iloperidone.

Materials and Methods: Randomized prospective study was conducted from December 2014 to August 2015 in the Department of Psychiatry, Tertiary Care Hospital, Mysore. 60 patients who met the criteria for acute psychosis and schizophrenia according to ICD 10 were recruited. Atypical antipsychotics, asenapine (5-20 mg), and iloperidone (8-24 mg) were administered, and their weight was measured using the digital weighing scale on day 0 (baseline), week 1, week 3, and week 6.

Results: Out of 60 recruited subjects, 51 (85%) completed all four visits of the study, 41.67% with asenapine, 43.3% with iloperidone. Mean weight gain was 2.18 ± 1.84 kg with iloperidone and 1.63 ± 1.28 kg with asenapine, but it was not statistically significant between the groups. Weight gain was dose dependent; 3.56 kg mean weight gain with 15-20 mg of asenapine and 3.36 kg with 18-24 mg iloperidone-treated patients which was statistically significant.

Conclusion: Mild to moderate weight gain was seen in both asenapine and iloperidone and it was dose dependent. Iloperidone showed more weight gain than asenapine.

Key words: Second-Generation Antipsychotics; Metabolic Adverse Effects; Weight Gain

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Nagesh HN Articles by Anil Kumar Nagaraj Articles by Kishore MS Articles by Narendra kumar MS
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Hn N, Nagaraj AK, Ms K, Ms NK. A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. Natl J Physiol Pharm Pharmacol. 2017; 7(1): 94-98.

doi:10.5455/njppp.2017.7.0721202082016

Web Style

Hn N, Nagaraj AK, Ms K, Ms NK. A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. https://www.njppp.com/?mno=237630 [Access: June 27, 2026].

doi:10.5455/njppp.2017.7.0721202082016

AMA (American Medical Association) Style

Hn N, Nagaraj AK, Ms K, Ms NK. A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. Natl J Physiol Pharm Pharmacol. 2017; 7(1): 94-98.

doi:10.5455/njppp.2017.7.0721202082016

Vancouver/ICMJE Style

Hn N, Nagaraj AK, Ms K, Ms NK. A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. Natl J Physiol Pharm Pharmacol. (2017), [cited June 27, 2026]; 7(1): 94-98.

doi:10.5455/njppp.2017.7.0721202082016

Harvard Style

Hn, N., Nagaraj, . A. K., Ms, . K. & Ms, . N. K. (2017) A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. Natl J Physiol Pharm Pharmacol, 7 (1), 94-98.

doi:10.5455/njppp.2017.7.0721202082016

Turabian Style

Hn, Nagesh, Anil Kumar Nagaraj, Kishore Ms, and Narendra Kumar Ms. 2017. A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. National Journal of Physiology, Pharmacy and Pharmacology, 7 (1), 94-98.

doi:10.5455/njppp.2017.7.0721202082016

Chicago Style

Hn, Nagesh, Anil Kumar Nagaraj, Kishore Ms, and Narendra Kumar Ms. "A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 94-98.

doi:10.5455/njppp.2017.7.0721202082016

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2017.7.0721202082016

APA (American Psychological Association) Style

Hn, N., Nagaraj, . A. K., Ms, . K. & Ms, . N. K. (2017) A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis. National Journal of Physiology, Pharmacy and Pharmacology, 7 (1), 94-98.

doi:10.5455/njppp.2017.7.0721202082016

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article